Shares of Kane Biotech Inc (CVE:KNE) traded up 23.1% during mid-day trading on Thursday . The stock traded as high as C$0.08 and last traded at C$0.08. 490,000 shares traded hands during mid-day trading, an increase of 971% from the average session volume of 45,745 shares. The stock had previously closed at C$0.07.
Kane Biotech (CVE:KNE) last posted its quarterly earnings results on Tuesday, August 21st. The company reported C($0.01) earnings per share (EPS) for the quarter. The company had revenue of C$0.10 million during the quarter. Kane Biotech had a negative return on equity of 172.74% and a negative net margin of 1,545.33%.
Kane Biotech Company Profile (CVE:KNE)
Kane Biotech Inc, a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; shampoo for dogs, cats, and horses under the Alosera trademark; and pet oral care solutions under the StrixNB and bluestem trademarks.
Featured Story: Balanced Fund
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.